Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-05-21 4:56 pm Purchase |
2024-05-20 | 13G | Rapid7, Inc. RPD |
Point72 Asset Management, L.P. | 3,121,415 5.000% |
1,243,804![]() (+66.24%) |
Filing History |
2024-05-09 5:29 pm Purchase |
2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Point72 Asset Management, L.P. | 17,050,384 9.900% |
17,050,384![]() (New Position) |
Filing History |
2024-04-26 4:15 pm Purchase |
2024-04-25 | 13G | Avid Bioservices, Inc. CDMO |
Point72 Asset Management, L.P. | 3,226,006 5.100% |
3,226,006![]() (New Position) |
Filing History |
2024-04-05 4:05 pm Purchase |
2024-04-04 | 13G | Sutro Biopharma, Inc. STRO |
Point72 Asset Management, L.P. | 5,932,908 7.900% |
5,932,908![]() (New Position) |
Filing History |
2024-03-26 4:21 pm Purchase |
2024-03-25 | 13G | Fox Corporation FOXA |
Point72 Asset Management, L.P. | 12,046,118 5.000% |
12,046,118![]() (New Position) |
Filing History |
2024-03-25 4:33 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
Point72 Asset Management, L.P. | 1,882,693 7.400% |
1,882,693![]() (New Position) |
Filing History |
2024-03-07 4:15 pm Purchase |
2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN |
Point72 Asset Management, L.P. | 3,921,226 6.300% |
3,921,226![]() (New Position) |
Filing History |
2024-02-29 4:31 pm Purchase |
2024-02-28 | 13G | Pulmonx Corporation LUNG |
Point72 Asset Management, L.P. | 1,936,083 5.000% |
389,994![]() (+25.22%) |
Filing History |
2024-02-27 4:14 pm Purchase |
2024-02-26 | 13G | Liberty Live Group LLYVA |
Point72 Asset Management, L.P. | 1,287,149 5.000% |
1,287,149![]() (New Position) |
Filing History |
2024-02-23 4:28 pm Purchase |
2024-02-22 | 13G | Ventyx Biosciences, Inc. VTYX |
Point72 Asset Management, L.P. | 3,017,093 5.100% |
3,017,093![]() (New Position) |
Filing History |
2024-02-23 4:15 pm Purchase |
2024-02-22 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management, L.P. | 4,432,602 5.000% |
435,057![]() (+10.88%) |
Filing History |
2024-02-21 4:16 pm Purchase |
2024-02-20 | 13G | Agenus Inc. AGEN |
Point72 Asset Management, L.P. | 1,413,425 6.800% |
1,413,368![]() (+2492389.95%) |
Filing History |
2024-02-14 4:20 pm Purchase |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 1,649,740 6.400% |
499,092![]() (+43.37%) |
Filing History |
2024-02-14 4:19 pm Purchase |
2023-12-31 | 13G | PagSeguro Digital Ltd. PAGS |
Point72 Asset Management, L.P. | 10,933,610 5.600% |
231,012![]() (+2.16%) |
Filing History |
2024-02-14 4:18 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management, L.P. | 3,030,283 5.800% |
30,283![]() (+1.01%) |
Filing History |
2024-02-14 4:17 pm Sale |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Point72 Asset Management, L.P. | 2,756,122 5.000% |
-866,014![]() (-23.91%) |
Filing History |
2024-02-14 4:17 pm Sale |
2023-12-31 | 13G | Madison Square Garden Entertainment Corp. MSGE |
Point72 Asset Management, L.P. | 2,299,168 5.600% |
-4,445![]() (-0.19%) |
Filing History |
2024-02-14 4:16 pm Purchase |
2023-12-31 | 13G | TPI Composites, Inc. TPIC |
Point72 Asset Management, L.P. | 3,286,322 7.100% |
1,154,151![]() (+54.13%) |
Filing History |
2024-02-14 4:15 pm Purchase |
2023-12-31 | 13G | Morphic Holding, Inc. MORF |
Point72 Asset Management, L.P. | 4,591,000 9.200% |
2,086,617![]() (+83.32%) |
Filing History |
2024-02-14 4:14 pm Sale |
2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 3,416,900 5.100% |
-311,052![]() (-8.34%) |
Filing History |